IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden · Delayed Price · Currency is SEK 0.3500
-0.0140 (-3.85%)
Mar 4, 2026, 5:01 PM CET
IDL Diagnostics AB Market Cap
IDL Diagnostics AB has a market cap or net worth of 80.63 million as of March 4, 2026. Its market cap has decreased by -40.68% in one year.
Market Cap
80.63M
Enterprise Value
57.29M
Revenue
53.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since May 25, 2011, IDL Diagnostics AB's market cap has increased from 16.78M to 80.63M, an increase of 380.55%. That is a compound annual growth rate of 11.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 83.85M | 3.12% |
| Dec 30, 2025 | 81.32M | -9.49% |
| Dec 30, 2024 | 89.84M | -10.76% |
| Dec 29, 2023 | 100.67M | -29.52% |
| Dec 30, 2022 | 142.82M | 31.17% |
| Dec 30, 2021 | 108.88M | -38.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 134.32B |
| Getinge AB | 54.07B |
| Sectra AB | 37.24B |
| Medicover AB | 32.84B |
| Vivesto AB | 91.67M |
| Biosergen AB | 90.17M |
| Scandinavian ChemoTech AB | 89.09M |
| Iconovo AB | 88.64M |